Detalles de la búsqueda
1.
Assessing the fiscal consequences of novel and existing treatments for triple negative breast cancer in Switzerland by applying a government perspective framework.
J Med Econ
; 27(1): 858-865, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38904118
2.
Real-world overall survival and characteristics of patients with ER-zero and ER-low HER2-negative breast cancer treated as triple-negative breast cancer: a Swedish population-based cohort study.
Lancet Reg Health Eur
; 40: 100886, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745990
3.
HTA and Reimbursement Status of Metastatic HormoneSensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review.
J Health Econ Outcomes Res
; 10(1): 102-110, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366384
4.
Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition.
Cell Rep
; 17(11): 2994-3009, 2016 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27974212
Resultados
1 -
4
de 4
1
Próxima >
>>